Canada invests in spinal injury research in a five-year programme:
This article was originally published in Clinica
Executive Summary
Canada has pledged Can$30m (US$25m) over five years to a foundation dedicated to research and treatment of spinal injury. The funds will be used by the Rick Hansen foundation's Spinal Cord Industry Translational Research Network to -accelerate scientific advances towards a cure" and to build infrastructure "needed to keep Canada on the leading edge of spinal cord research". Other objectives of the foundation include establishing best practices in spinal cure treatment, acceleration of practical application of cures and completing the roll-out of a national registry of patients and their medical histories as a reporting and tracking tool.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.